Tower Research Capital LLC (Trc) Acumen Pharmaceuticals, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,910 shares of ABOS stock, worth $6,138. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,910
Previous 26,488
85.24%
Holding current value
$6,138
Previous $64,000
85.94%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ABOS
# of Institutions
77Shares Held
41.8MCall Options Held
57.7KPut Options Held
749K-
Ra Capital Management, L.P. Boston, MA14.9MShares$23.4 Million0.52% of portfolio
-
Franklin Resources Inc San Mateo, CA3.55MShares$5.57 Million0.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$5.36 Million4.37% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.3MShares$3.61 Million0.19% of portfolio
-
Black Rock Inc. New York, NY2.16MShares$3.39 Million0.0% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $63.6M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...